These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19356058)

  • 21. A convenient strategy to overcome interference in LC-MS/MS analysis: Application in a microdose absolute bioavailability study.
    Yuan L; Huang C; Liu-Kreyche P; Voronin K; Fancher RM; Allentoff A; Zheng N; Iyer R; Zhu L; Pillutla R; Ji QC
    J Pharm Biomed Anal; 2019 Feb; 165():198-206. PubMed ID: 30553110
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of a probe for assessing deconjugation of glucuronide and sulfate phase II metabolites assayed through LC-MS/MS in biological matrices.
    Grignon C; Dupuis A; Albouy-Llaty M; Condylis M; Barrier L; Carato P; Brunet B; Migeot V; Venisse N
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():72-78. PubMed ID: 28710970
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a new method for the quantitation of metabolites in the absence of chemically synthetized authentic standards.
    Altares R; Márquez Del Pino FM; Benedit G; Guillén MJ; Cuevas C; Pérez de la Cruz MA; Aviles P
    J Pharm Biomed Anal; 2019 May; 169():70-74. PubMed ID: 30831452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LC-MS/MS detection of unaltered glucuronoconjugated metabolites of metandienone.
    Esquivel A; Pozo OJ; Garrostas L; Balcells G; Gómez C; Kotronoulas A; Joglar J; Ventura R
    Drug Test Anal; 2017 Apr; 9(4):534-544. PubMed ID: 27237125
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Introduction to early in vitro identification of metabolites of new chemical entities in drug discovery and development.
    Baranczewski P; Stańczak A; Kautiainen A; Sandin P; Edlund PO
    Pharmacol Rep; 2006; 58(3):341-52. PubMed ID: 16845208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-analyte approach to help in assessing the severity of acute poisonings - Development and validation of a fast LC-MS/MS quantification approach for 45 drugs and their relevant metabolites with one-point calibration.
    Michely JA; Maurer HH
    Drug Test Anal; 2018 Jan; 10(1):164-176. PubMed ID: 28777878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of docetaxel and its metabolites in human plasma by liquid chromatography/tandem mass spectrometry.
    Hendrikx JJ; Dubbelman AC; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
    Rapid Commun Mass Spectrom; 2013 Sep; 27(17):1925-34. PubMed ID: 23939959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolite identification of a new tyrosine kinase inhibitor, HM781-36B, and a pharmacokinetic study by liquid chromatography/tandem mass spectrometry.
    Kim E; Kim H; Suh K; Kwon S; Lee G; Park NH; Hong J
    Rapid Commun Mass Spectrom; 2013 Jun; 27(11):1183-95. PubMed ID: 23650031
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel strategies for microdose studies using non-radiolabeled compounds.
    Maeda K; Sugiyama Y
    Adv Drug Deliv Rev; 2011 Jun; 63(7):532-8. PubMed ID: 21345359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A rapid method for quantitatively estimating metabolites in human plasma in the absence of synthetic standards using a combination of liquid chromatography/mass spectrometry and radiometric detection.
    Yu C; Chen CL; Gorycki FL; Neiss TG
    Rapid Commun Mass Spectrom; 2007; 21(4):497-502. PubMed ID: 17221928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bio-generation of stable isotope-labeled internal standards for absolute and relative quantitation of phase II drug metabolites in plasma samples using LC-MS/MS.
    Li P; Li Z; Beck WD; Callahan PM; Terry AV; Bar-Peled M; Bartlett MG
    Anal Bioanal Chem; 2015 May; 407(14):4053-63. PubMed ID: 25804729
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of exposure multiples of human metabolites for MIST assessment in preclinical safety species without using reference standards or radiolabeled compounds.
    Ma S; Li Z; Lee KJ; Chowdhury SK
    Chem Res Toxicol; 2010 Dec; 23(12):1871-3. PubMed ID: 21121646
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New drostanolone metabolites in human urine by liquid chromatography time-of-flight tandem mass spectrometry and their application for doping control.
    Liu Y; Lu J; Yang S; Zhang Q; Xu Y
    Steroids; 2016 Apr; 108():61-7. PubMed ID: 26826321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of conjugation positions of urinary glucuronidated vitamin D
    Yoshimura Y; Hibi R; Nakata A; Togashi M; Ogawa S; Ishige T; Satoh M; Nomura F; Higashi T
    Biomed Chromatogr; 2019 Jul; 33(7):e4538. PubMed ID: 30912169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Addressing MIST (Metabolites in Safety Testing): bioanalytical approaches to address metabolite exposures in humans and animals.
    Gao H; Obach RS
    Curr Drug Metab; 2011 Jul; 12(6):578-86. PubMed ID: 21434861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liquid chromatography-tandem mass spectrometry assay for the quantitation of plagiochin E and its main metabolite plagiochin E glucuronides in rat plasma.
    Xing J; Lv B; Xie C; Qu J; Lou H
    J Pharm Biomed Anal; 2008 Aug; 47(4-5):949-53. PubMed ID: 18420369
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of nine drugs and their cytochrome P450-specific probe metabolites from urine by liquid chromatography-tandem mass spectrometry utilizing sub 2 microm particle size column.
    Petsalo A; Turpeinen M; Pelkonen O; Tolonen A
    J Chromatogr A; 2008 Dec; 1215(1-2):107-15. PubMed ID: 19019380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pitfalls associated with the use of liquid chromatography-tandem mass spectrometry in the clinical laboratory.
    Vogeser M; Seger C
    Clin Chem; 2010 Aug; 56(8):1234-44. PubMed ID: 20511452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenges and recommendations in developing LC-MS/MS bioanalytical assays of labile glucuronides and parent compounds in the presence of glucuronide metabolites.
    Yuan L; Sophia Xu X; Ji QC
    Bioanalysis; 2020 May; 12(9):615-624. PubMed ID: 32441529
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of a rapid and sensitive LC-MS/MS method for determination of exemestane and its metabolites, 17β-hydroxyexemestane and 17β-hydroxyexemestane-17-O-β-D-glucuronide: application to human pharmacokinetics study.
    Wang LZ; Goh SH; Wong AL; Thuya WL; Lau JY; Wan SC; Lee SC; Ho PC; Goh BC
    PLoS One; 2015; 10(3):e0118553. PubMed ID: 25793887
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.